CoronaVac
{{Infobox drug
| drug_name          = 
| type               = Paksin
| image              = SINOVAC COVID-19 vaccine.jpg
| alt                = 
| caption            = 
| target             = [[COVID-19]]
| vaccine_type 	= SARS-CoV-2 inaktif
<!-- Clinical data -->
| pronounce          = 
| tradename          = 
| Drugs.com          = 
| MedlinePlus        = 
| licence_EU         = 
| licence_US         = 
| pregnancy_AU       = <!-- A/B1/B2/B3/C/D/X -->
| pregnancy_category = 
| legal_AU           = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment   = 
| legal_BR           = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment   = 
| legal_CA           = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK           = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US           = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_UN           = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_NZ           = <!--Class A, B, C -->
| legal_status       = Pamakaian kapalipitan di [[Ripublik Rakyat Cina|Tiongkok]], [[Indunisia]], [[Brasil]], wan [[Turki]]
| routes_of_administration = [[Penyuntikan intraotot]]
<!-- Identifiers -->
| CAS_number         = 
| ATCvet             = 
| ATC_prefix         = None
| ATC_suffix         = 
| PubChem            = 
| DrugBank           = DB15806
}}

'''CoronaVac''' adalah [[vaksin COVID-19]] nang dikambangakan ulih pausahaan biofarmasi Tiongkok, [[Sinovac Biotech|Sinovac]].<ref name="jakartaglobe">{{Cite web|date=August 11, 2020|title=Indonesia Starts CoronaVac Phase 3 Clinical Trials|url=https://jakartaglobe.id/news/indonesia-starts-coronavac-phase-3-clinical-trials|website=Jakarta Globe|archive-url=https://web.archive.org/web/20201013211900/https://jakartaglobe.id/news/indonesia-starts-coronavac-phase-3-clinical-trials|archive-date=October 13, 2020|access-date=2020-08-26|url-status=live}}</ref> Matan patangahan tahun 2020, calun paksin ngini manjalani [[Tahap-tahap paitihan klinis|paitihan klinis tahap III]],<ref name="NCname= nct04456595=">{{ClinicalTrialsGov|NCT04456595|Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)}}</ref><ref>{{Cite web|date=August 10, 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18-59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|website=PT Bio Farma|publisher=Registri Penyakit Indonesia|archive-url=https://web.archive.org/web/20201011084814/https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F|archive-date=October 11, 2020|access-date=August 15, 2020|url-status=live}}</ref> wan mandapatakan pasatujuan gasan pamakaian kapalipitan nang damini balangsung di Brasil, Chili, Indunisia, wan Turki. CoronaVac mamakai tiknulugi sarupa, tagal labih taradisiunal, dibandingakan lawan [[BBIBP-CorV]] wan [[BBV152]], paksin pirus inaktip COVID-19 lainnya nang jua rahatan dalam panaraian tahap III.<ref>{{Cite news|date=2020-06-10|title=Coronavirus Vaccine Tracker|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|work=The New York Times|language=en-US|issn=0362-4331|access-date=2020-12-27}}</ref>

[[Brasil]] mamadahakan tingkat kamanjuran (efikasi) CoronaVac saganal 50,38% wayah 12 Januari 2021 badasarakan data langkap matan panaraian wayah 12.508 paumpatn; tingkat kamanjuran ngini parak 30% labih randah matan kulih nang dipadahakan sabalumnya wan parak kada mayu gasan mandapatakan pasatujuan matan WHO wan Brasil.<ref>{{Cite web|title=Vacina CoronaVac tem eficácia global de 50,38% nos testes feitos no Brasil, diz Instituto Butantan|url=https://g1.globo.com/sp/sao-paulo/noticia/2021/01/12/vacina-coronavac-tem-eficacia-global-de-504percent-nos-testes-feitos-no-brasil-diz-instituto-butantan.ghtml|website=G1|language=pt-br|access-date=2021-01-12}}</ref><ref name="bloo_HowE">{{Cite web|last=Hong|first=Jinshan|date=January 12, 2021|title=How Effective Is China's Sinovac Vaccine? Data Confuse Experts|url=https://www.bloomberg.com/news/articles/2021-01-12/china-vaccine-going-global-with-four-different-efficacy-rates|access-date=January 12, 2021|agency=[[Bloomberg News]]}}</ref><ref name="wsj._Chin">{{Cite web|last=Pearson|first=Samantha|last2=Magalhaes|first2=Luciana|date=12 January 2021|title=Chinese Covid-19 Vaccine Is Far Less Effective Than Initially Touted in Brazil|url=https://www.wsj.com/articles/chinas-sinovac-covid-19-vaccine-is-50-4-in-late-stage-brazil-trials-11610470581|access-date=12 January 2021|newspaper=[[The Wall Street Journal]]}}</ref> [[Instituto Butantan]], panyalanggara panaraian, mamadahakan angka nang labih randah marga rata-rata pahitungan jangkitan nang takantat dibandingakan lawan paulah paksin lainnya.<ref name=":6">{{Cite web|title=Why did the efficacy of China’s top vaccine drop from 78% to 50%?|url=https://fortune.com/2021/01/13/sinovac-vaccine-efficacy-rate-drop/|website=Fortune|language=en|access-date=2021-01-14}}</ref> Sabalumnya, wayah 7 Januari 2021, Instituto Butantan mamadahakan lamun paksin ngini 78% manjur lawan kajadian hampul wan 100% manjur malawan jangkitan barat wan sadang badasarakan 220 kajadian COVID-19 matan 13.000 sakarilawan kadada marinci badimapa tingkat kamanjurannya dihitung.<ref name=":2">{{Cite news|date=2021-01-07|title=Sinovac’s Covid Shot Proves 78% Effective in Brazil Trial|url=https://www.bloomberg.com/news/articles/2021-01-07/sinovac-covid-shot-78-effective-in-brazil-trial-folha-reports|work=Bloomberg.com|language=en|access-date=2021-01-07}}</ref> 

[[Turki]] sabalumnya sudah mamadahakan tingkat kamanjuran saganal 91,25% matan analisis samantara tahadap 29 kajadian nang didasarakan lawan data matan 1.322 paumpat dalam panaraian lawan 7.371 sakarilawan,<ref name="reut_Piec">{{Cite web|last=Staff|first=Reuters|date=December 28, 2020|title=Piecemeal data releases threaten to undermine Sinovac's COVID-19 vaccine|url=https://www.reuters.com/article/health-coronavirus-sinovac/piecemeal-data-releases-threaten-to-undermine-sinovacs-covid-19-vaccine-idINKBN2920RT|access-date=January 11, 2021|agency=[[Reuters]]}}</ref><ref name="nyti_Turk">{{Cite web|last=Zimmer|first=Carl|last2=Londoño|first2=Ernesto|date=December 25, 2020|title=Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data|url=https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html|access-date=January 11, 2021|newspaper=[[The New York Times]]}}</ref><ref name=":0">{{Cite web|title=Turkish official says CoronaVac vaccine 91.25% effective|url=https://abcnews.go.com/Health/wireStory/turkish-official-coronavac-vaccine-9125-effective-74899577|website=ABC News|language=en|access-date=2020-12-26}}</ref><ref name=":8">{{Cite web|date=December 25, 2020|title=Turkey set to receive 'effective' COVID-19 vaccine amid calls for inoculation|url=https://www.dailysabah.com/turkey/turkey-set-to-receive-effective-covid-19-vaccine-amid-calls-for-inoculation/news|website=Daily Sabah|language=en|access-date=December 26, 2020}}</ref> samantara Indunisia mamadahakan tingkat kamanjuran saganal 65,3% badasarakan data matan 1.600 paumpat dalam panaraian bubuhannya.<ref name=":5">{{Cite web|last=hermesauto|date=2021-01-11|title=Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy|url=https://www.straitstimes.com/asia/se-asia/indonesia-grants-emergency-use-approval-to-sinovac-vaccine-local-trials-show-65|website=The Straits Times|language=en|access-date=2021-01-11}}</ref>

== Jujuhutan ==
CoronaVac adalah vaksin COVID-19 nang dikambangakan ulih pausahaan biofarmasi Tiongkok, Sinovac. Matan patangahan tahun 2020, calun paksin ngini manjalani paitihan klinis tahap III, wan mandapatakan pasatujuan gasan pamakaian kapalipitan nang damini balangsung di Brasil, Chili, Indunisia, wan Turki. CoronaVac mamakai tiknulugi sarupa, tagal labih taradisiunal, dibandingakan lawan BBIBP-CorV wan BBV152, paksin pirus inaktip COVID-19 lainnya nang jua rahatan dalam panaraian tahap III.

Brasil mamadahakan tingkat kamanjuran (efikasi) CoronaVac saganal 50,38% wayah 12 Januari 2021 badasarakan data langkap matan panaraian wayah 12.508 paumpatn; tingkat kamanjuran ngini parak 30% labih randah matan kulih nang dipadahakan sabalumnya wan parak kada mayu gasan mandapatakan pasatujuan matan WHO wan Brasil. Instituto Butantan, panyalanggara panaraian, mamadahakan angka nang labih randah marga rata-rata pahitungan jangkitan nang takantat dibandingakan lawan paulah paksin lainnya. Sabalumnya, wayah 7 Januari 2021, Instituto Butantan mamadahakan lamun paksin ngini 78% manjur lawan kajadian hampul wan 100% manjur malawan jangkitan barat wan sadang badasarakan 220 kajadian COVID-19 matan 13.000 sakarilawan kadada marinci badimapa tingkat kamanjurannya dihitung. 

Turki sabalumnya sudah mamadahakan tingkat kamanjuran saganal 91,25% matan analisis samantara tahadap 29 kajadian nang didasarakan lawan data matan 1.322 paumpat dalam panaraian lawan 7.371 sakarilawan, samantara Indunisia mamadahakan tingkat kamanjuran saganal 65,3% badasarakan data matan 1.600 paumpat dalam panaraian bubuhannya.

 Jujuhutan